AQR Capital Management
RXII

AQR Capital Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

AQR Capital Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-75,000
Closed -$155K – 2792
2014
Q3 		$155K Buy
+75,000
New +$155K ﹤0.01% 2397
2014
Q2 		– Sell
-115,800
Closed -$290K – 2703
2014
Q1 		$290K Buy
115,800
+103,600
+849% +$259K ﹤0.01% 2277
2013
Q4 		$61K Sell
12,200
-102,900
-89% -$515K ﹤0.01% 2543
2013
Q3 		$261K Sell
115,100
-36,600
-24% -$83K ﹤0.01% 2260
2013
Q2 		$337K Buy
+151,700
New +$337K ﹤0.01% 2056

Other funds holding RXII

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

AQR Capital Management's RXII Position: Q4 2014 in Review

AQR Capital Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2014, closing a stake of 75,000 shares — an estimated $155K sold.

AQR Capital Management first reported a position in RXII in Q2 2013 and held it in 5 quarters. The position peaked at $337K in Q2 2013. 79 funds tracked by Wall St. Rank hold RXII as of Q4 2014.

  • AQR Capital Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2014 after selling out during the quarter.
  • AQR Capital Management sold 75,000 GALENA BIOPHARMA INC COM shares in Q4 2014, an estimated $155K.
  • AQR Capital Management first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 5 quarters.
  • AQR Capital Management's GALENA BIOPHARMA INC COM position peaked at $337K in Q2 2013.
  • 79 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2014.

Based on AQR Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.